Figure 2From: Cytokines, GM-CSF and IFNγ administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatinHematologic Cell Counts as Function of Time in 25 patients. "Pre" – Study Baseline; "D" – day number preceding first cycle (D-) or following (D+) carboplatin ("C") administration; "3M" – 3 months after initiation of therapy. Values are expressed as means and 95% CIs.Back to article page